109 related articles for article (PubMed ID: 32756574)
1. Travel time to care does not affect survival for patients with colorectal cancer in northern Sweden: A data linkage study from the Risk North database.
Sjöström O; Dahlin AM; Silander G; Syk I; Melin B; Hellquist BN
PLoS One; 2020; 15(8):e0236799. PubMed ID: 32756574
[TBL] [Abstract][Full Text] [Related]
2. Impact of travel time and rurality on presentation and outcomes of symptomatic colorectal cancer: a cross-sectional cohort study in primary care.
Murage P; Murchie P; Bachmann M; Crawford M; Jones A
Br J Gen Pract; 2017 Jul; 67(660):e460-e466. PubMed ID: 28583943
[TBL] [Abstract][Full Text] [Related]
3. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.
Magaji BA; Moy FM; Roslani AC; Law CW
BMC Cancer; 2017 May; 17(1):339. PubMed ID: 28521746
[TBL] [Abstract][Full Text] [Related]
4. Can composite performance measures predict survival of patients with colorectal cancer?
Chung KP; Chen LJ; Chang YJ; Chang YJ
World J Gastroenterol; 2014 Nov; 20(42):15805-14. PubMed ID: 25400466
[TBL] [Abstract][Full Text] [Related]
5. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
6. Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population.
Meyerhardt JA; Kroenke CH; Prado CM; Kwan ML; Castillo A; Weltzien E; Cespedes Feliciano EM; Xiao J; Caan BJ
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):30-37. PubMed ID: 27986654
[TBL] [Abstract][Full Text] [Related]
7. Identification of patients with non-metastatic colorectal cancer in primary care: a case-control study.
Ewing M; Naredi P; Zhang C; Månsson J
Br J Gen Pract; 2016 Dec; 66(653):e880-e886. PubMed ID: 27821670
[TBL] [Abstract][Full Text] [Related]
8. Travel distance influences readmissions in colorectal cancer patients-what the primary operative team needs to know.
Kelley KA; Young JI; Bassale S; Herzig DO; Martindale RG; Sheppard BC; Lu KC; Tsikitis VL
J Surg Res; 2018 Jul; 227():220-227. PubMed ID: 29804856
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
11. No difference between lowest and highest volume hospitals in outcome after colorectal cancer surgery in the southern Netherlands.
van Erning FN; van Steenbergen LN; van den Broek WT; Rutten HJ; Lemmens VE
Eur J Surg Oncol; 2013 Nov; 39(11):1199-206. PubMed ID: 24044806
[TBL] [Abstract][Full Text] [Related]
12. Differences according to educational level in the management and survival of colorectal cancer in Sweden.
Cavalli-Björkman N; Lambe M; Eaker S; Sandin F; Glimelius B
Eur J Cancer; 2011 Jun; 47(9):1398-406. PubMed ID: 21237637
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer survival: results from a hospital-based cancer registry.
Agüero F; Murta-Nascimento C; Gallén M; Andreu-García M; Pera M; Hernández C; Burón A; Macià F
Rev Esp Enferm Dig; 2012 Dec; 104(11):572-7. PubMed ID: 23368648
[TBL] [Abstract][Full Text] [Related]
14. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
15. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s.
Kim SP; Feinglass J; Bennett CL; Lyons T; Simon C; Weinberg MN; Talamonti MS
Cancer Invest; 2004; 22(2):225-33. PubMed ID: 15199605
[TBL] [Abstract][Full Text] [Related]
16. Time trends of short-term mortality for octogenarians undergoing a colorectal resection in North Europe.
Claassen YHM; Bastiaannet E; van Eycken E; Van Damme N; Martling A; Johansson R; Iversen LH; Ingeholm P; Lemmens VEPP; Liefers GJ; Holman FA; Dekker JWT; Portielje JEA; Rutten HJ; van de Velde CJH
Eur J Surg Oncol; 2019 Aug; 45(8):1396-1402. PubMed ID: 31003722
[TBL] [Abstract][Full Text] [Related]
17. Is there a rationale to record lymphatic invasion in node-positive colorectal cancer?
Betge J; Schneider NI; Pollheimer MJ; Lindtner RA; Kornprat P; Schlemmer A; Rehak P; Langner C
J Clin Pathol; 2012 Sep; 65(9):847-50. PubMed ID: 22569541
[TBL] [Abstract][Full Text] [Related]
18. Impact of travel distance on access to treatment and survival in patients with metastatic colorectal cancer prescribed bevacizumab plus chemotherapy.
Payette E; Sarker S; Chalchal H
Can J Rural Med; 2017; 22(4):148-152. PubMed ID: 28925914
[TBL] [Abstract][Full Text] [Related]
19. Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival.
Roder D; Karapetis CS; Olver I; Keefe D; Padbury R; Moore J; Joshi R; Wattchow D; Worthley DL; Miller CL; Holden C; Buckley E; Powell K; Buranyi-Trevarton D; Fusco K; Price T
BMJ Open; 2019 Sep; 9(9):e031421. PubMed ID: 31575579
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumour deposit and perineural invasion status in colorectal cancer patients: a SEER-based population study.
Mayo E; Llanos AA; Yi X; Duan SZ; Zhang L
Histopathology; 2016 Aug; 69(2):230-8. PubMed ID: 26802566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
